COVID-19 presents challenges for treating multiple myeloma patients. Joshua Richter, MD, discusses recommendations for modifying care plans to treat patients safely and effectively.
Related Presenters
Assistant Professor, Medicine (Hematology and Medical Oncology)
Icahn School of Medicine at Mount Sinai
Site Director of Myeloma Services, The Blavatnik Family – Chelsea Medical Center at Mount Sinai, Center of Excellence for Multiple Myeloma
Related Videos
